At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...